News

Keryx Biopharmaceuticals has announced updated clinical results from a phase 2 study of KRX-0401 (perifosine), the company’s PI3K/Akt pathway inhibitor for cancer, as a single-agent treatment for advanced

PolyMedix has initiated dosing and commenced a second clinical trial, a phase 1B pilot proof of concept study, in the US with its anticoagulant reversing agent PMX-60056 under

Camlin Fine Chemicals of Camlin, the maker of a popular range of stationery products, said it does not have plans to sell the API business, clarifying the announcement

BioTech Medics has announced that they have entered into a wholesaler Distribution Agreement for BioTech’s patented and exclusive Shban Antimicrobial Hand Sanitizer Products with a Dubai distributor. The

Hovione’s API manufacturing plant in Loures, Portugal has successfully passed a pre-approval inspection by FDA. The inspection lasted 5 days starting on 21st September and concluded on the

The Special Committee of Independent Directors of Patheon and Lonza have announced the extension until October 15, 2009 of the exclusivity and due diligence period. The step is

Plex Systems has announced that Inteva has completed the launch of Plex Online at 14 of its global locations, including sites spanning two continents, four countries and four

Johnson & Johnson, through its subsidiary Ortho-McNeil-Janssen Pharmaceuticals, and Crucell have entered into a strategic collaboration focusing on the discovery, development and commercialisation of monoclonal antibodies and vaccines

UCB and AstraZeneca have entered into a partnership to register and commercialise UCB’s PEGylated anti-TNF alpha drug Cimzia (certolizumab pegol) in Brazil. The drug is to be registered